Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Acta Academiae Medicinae Sinicae ; (6): 301-306, 2003.
Artículo en Chino | WPRIM | ID: wpr-350104

RESUMEN

<p><b>OBJECTIVE</b>To develop a therapeutic vaccine against human tumors associated with human papillomavirus type 16E6E7 (HPV16E6E7) which is modified from a Chinese patient of the cervical cancer which possessing the antigenicity and no transforming activity, and explore more active vaccine for inducing cellular immunity with mouse co-stimulatory molecular B7-1 gene.</p><p><b>METHODS</b>The modified E6E7 gene expression plasmid pVR1012-fmE6E7 was constructed and transfected Cos-7 cells, and the E7 protein specific expression was testified by immunofluorescence assay. C57BL/6 mice were immunized intramuscularly with pVR1012-fmE6E7 alone or in combination with B7-1 gene expression plasmid (pcDNA3.1-B7-1). The activity of cytotoxic T lymphocytes (CTLs) was analyzed with 51Cr specific release assay and the specific antibody in sera was analyzed by indirect ELISA. HPV16 positive C57BL/6 tumor cells C3 were inoculated subcutaneously in the vaccinated mice to assay the growth of transplanted tumors.</p><p><b>RESULTS</b>The specific CTLs and antibody from immunized mice were induced efficaciously by the E6E7 gene immunization, and co-administration of B7-1 gene could significantly enhanced the CTLs immune responses of fmE6E7, and protected 33% immunized mice against C3 tumor cells challenge. In contrast, all the mice immunized only with fmE6E7 gene developed transplanted tumors after C3 cells challenge. There was no difference in E7 specific antibody responses between mice immunized with the E6E7 gene only and co-administration with B7-1 gene.</p><p><b>CONCLUSIONS</b>The modified E6E7 gene can be used as target gene for developing DNA vaccine, and B7-1 gene may represent an attractive adjuvant for enhancement of the specific cellular immune responses.</p>


Asunto(s)
Animales , Femenino , Ratones , Anticuerpos Antineoplásicos , Alergia e Inmunología , Antígeno B7-1 , Genética , Alergia e Inmunología , Ratones Endogámicos C57BL , Trasplante de Neoplasias , Proteínas Oncogénicas Virales , Genética , Alergia e Inmunología , Proteínas E7 de Papillomavirus , Proteínas Represoras , Linfocitos T Citotóxicos , Alergia e Inmunología , Transfección , Neoplasias del Cuello Uterino , Alergia e Inmunología , Patología , Virología , Vacunas de ADN , Alergia e Inmunología
2.
Acta Academiae Medicinae Sinicae ; (6): 397-400, 2002.
Artículo en Chino | WPRIM | ID: wpr-278155

RESUMEN

<p><b>OBJECTIVE</b>To identify and assess multiple human papillomavirus types in condyloma acuminatum lesions from patients with genital warts in Beijing area, and compare different features between otherwise healthy and immunosuppressed patients.</p><p><b>METHODS</b>PCR, RFLP and nucleotide sequencing analysis were used to determine HPV types from individual lesions.</p><p><b>RESULTS</b>The predominant type from other healthy patients was HPV6, secondly HPV11. The mean age of patients infected by HPV6 was lower than that of HPV11 and HPV6 + 11. While lesions from immunosuppressed patients were often contained HPV11 or mixed with HPV6. Besides, HPV types 16 and 53 were detected from infected lesions than other HPV types.</p><p><b>CONCLUSIONS</b>HPV6 was the major pathogen of condyloma acuminatum, but infected patients were at lower ages. While HPV11 was most often detected from immunosuppressed patients. As a low risk virus in normal genital tract, HPV53 also could be a pathogen in genital warts.</p>


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Condiloma Acuminado , Virología , Papillomaviridae , Clasificación , Infecciones por Papillomavirus , Infecciones Tumorales por Virus , Verrugas , Virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA